Diagnosis of neonatal sepsis in low resource settings: C-reactive protein or procalcitonin?

Abstract C-reactive protein (CRP) is a biological marker currently used in the diagnosis of several infectious diseases. It has been widely used in the diagnosis and follow-up of treatment in neonatal sepsis. With the recent development of newer diagnostic markers, especially procalcitonin (PCT) tha...

Full description

Saved in:
Bibliographic Details
Published inJournal of pediatric biochemistry Vol. 3; no. 2; pp. 079 - 083
Main Authors Chiabi, Andreas, Mbuagbaw, Lawrence, Monebenimp, Francisca, Obadeyi, Bolaji, Bissohong, Grace, Obama, Marie-Thérèse
Format Journal Article
LanguageEnglish
Published New York Georg Thieme Verlag KG 01.01.2013
Stuttgart
Subjects
Review Article
low resource settings
procalcitonin
diagnosis
neonatal sepsis
C-reactive protein
Online AccessGet full text

Cover

More Information
Summary:Abstract C-reactive protein (CRP) is a biological marker currently used in the diagnosis of several infectious diseases. It has been widely used in the diagnosis and follow-up of treatment in neonatal sepsis. With the recent development of newer diagnostic markers, especially procalcitonin (PCT) that are more specific and sensitive though more expensive, the role of CRP requires appraisal. We sought to re-examine its use in low resource settings that carry the highest burden and mortality from neonatal sepsis. We argue that it is easy to perform, cost-effective and is still a valuable tool for making quick decisions in the diagnosis and management of neonatal sepsis, despite new emerging biological markers.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:1879-5390
1879-5404
DOI:10.3233/JPB-130077